Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Friendly’s and Hershey’s ice creams among nearly 70 products recalled over risk of listeria contamination

Recall impacted over a dozen brands but FDA says no illnesses yet reported from potential contamination

The Independent UK

FDA warns maker of Sara Lee and Entenmann's not to claim foods contain allergens when they don't

Federal food safety regulators are warning Bimbo Bakeries USA to stop using misleading labels that say products contain potentially dangerous allergens when they don't

The Independent UK

FDA authorized the sale of menthol-flavored e-cigarettes – a health policy expert explains how the benefits may outweigh the risks

On June 21, 2024, the U.S. Food and Drug Administration authorized the marketing of the first electronic cigarette products in flavors other than tobacco in the U.S. Of the four new authorized products, two are sealed, prefilled pods with menthol flavored nicotine liquid that can be used in certain types…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Baby boomers are abusing marijuana at a higher rate as more Medicare beneficiaries turn to cannabis with ‘little other safe choices for pain or sleep’

People are living longer and looking for ways to ease the symptoms of aging, according to a medical marijuana expert.

Fortune

3 Healthcare Stocks With Strong Profit Margins to Buy Now

The healthcare industry is poised to grow rapidly due to the rising need for medical aid, government initiatives, and increasing chronic diseases contributing to overall stability. Given the industry’s promising prospects, investors could consider buying quality healthcare stocks: UnitedHealth Group (UNH), Johnson & Johnson (JNJ), and AbbVie (ABBV), with strong…

StockNews.com

FDA Belatedly and Arbitrarily Approves Menthol Vapes

The agency's inscrutable approach to harm-reducing nicotine products sacrifices consumer choice and public health on the altar of youth protection.

Reason

‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu outbreak

The U.S. stock is inadequate for a H5N1 pandemic. It’s time to ramp up solutions.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval

Argenx stock surged Monday after the FDA approved its drug, Vyvgart Hytrulo, for patients with an autoimmune condition known as CIDP.

Investors Business Daily

The Future of Weight-Loss Drugs for Investors

Weight-loss drugs’ impact could reach far beyond their target user, potentially creating headwinds for shares of snack makers and packaged-food firms, as well as medical device makers that specialize in knee replacements, insulin pumps and sleep apnea machines.

Kiplinger

"Flying blind" with bird flu

Testing failures are a key reason the U.S. fared so poorly with COVID. Are we repeating these mistakes with H5N1?

Salon

FDA OKs first menthol e-cigarettes, citing potential to help adult smokers

The Food and Drug Administration has authorized the first menthol-flavored electronic cigarettes for adult smokers

The Independent UK

FDA Authorizes First Menthol E-Cigarettes For Adult Smokers

FDA authorizes first menthol e-cigarettes for adult smokers, sparking debate on harm reduction and youth appeal in vaping industry.

Top News

Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance

The Nasdaq and S&P 500 backed off fresh record highs as Nvidia and AI chip stocks retreated late in the week.

Investors Business Daily

Is This Growth Stock Under $10 With 370% Upside a Buy Right Now?

This biotech company has some promising candidates in its pipeline. Could this minor setback slow the company's progress?

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Reason

Boom in DIY Medical Testing Gives Americans More Control Over Their Health

Thanks to clever inventions and investments from venture capitalists, the average American can head to CVS and purchase kits to test for drug use, sexually transmitted diseases, AIDs, diabetes, blood pressure and cholesterol.

Investors Business Daily

Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy

Sarepta stock rocketed Friday after hitting a "grand slam" approval that expands the market for its Duchenne muscular dystrophy gene therapy more than tenfold, according to one estimate.

Reason

If Opiates Are Killing Americans, Why Won't the FDA Let Us Try an Alternative?

As the DEA relentlessly tightens regulations on pain meds, the FDA refuses to approve a safer alternative already being used in similar countries.

The Conversation

Lawsuit could challenge trust in Ozempic and other popular weight loss drugs

The manufacturers of the most popular weight loss drugs are being challenged in court.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry

In the last few decades, scientists have finally learned to harness the immune system to successfully treat cancer. Although doctors often use immunotherapy drugs, another type of treatment uses patient’s cells to treat their own cancers.

Fortune

Older women's health is woefully understudied

The health of older women is a largely neglected group in medical research.

The Independent UK

Dollar Tree left lead-tainted applesauce pouches on store shelves for weeks after recall, FDA says

Government officials say Dollar Tree stores failed to effectively recall lead-tainted applesauce pouches linked to illness in more than 500 U.S. children

Reason

Journal of Free Speech Law: "FDA Regulation of Physicians' Professional Speech," by Prof. Barbara J. Evans

An early article from what will eventually be several on Information as Medicine.

Top News

Democratic Governors Stockpile Abortion Pills In Resistance Against Trump

Democratic and leftist groups prepare for potential challenges to abortion access under a Trump administration, with blue state governors stockpiling Mifep...

Fortune

What to know about 'preventative Botox'

Are the risks and costs worth it to keep crow's feet at bay? Experts weigh in.

The Independent UK

Drug shortages keep on growing. Older, injectable medicines are among the most vulnerable

Erin Fox has tracked drug shortages for more than 20 years, and she sees no easy solutions for what has become a record run

1 … 62 63 64 65

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.